Search hospitals > Illinois > O'Fallon
Memorial Hospital East
Claim this profileO'Fallon, Illinois 62269
Global Leader in Breast Cancer
Global Leader in Lung Cancer
Conducts research for Breast cancer
Conducts research for Cancer
Conducts research for Pancreatic Cancer
35 reported clinical trials
27 medical researchers
Summary
Memorial Hospital East is a medical facility located in O'Fallon, Illinois. This center is recognized for care of Breast Cancer, Lung Cancer, Breast cancer, Cancer, Pancreatic Cancer and other specialties. Memorial Hospital East is involved with conducting 35 clinical trials across 116 conditions. There are 27 research doctors associated with this hospital, such as Douglas R. Adkins, Saiama N. Waqar, Kian-Huat Lim, M.D., Ph.D., and Tanner M Johanns, M.D., Ph.D..Area of expertise
1Breast Cancer
Global LeaderStage IV
ER positive
HER2 negative
2Lung Cancer
Global LeaderStage IV
Stage II
Stage III
Top PIs
Douglas R. AdkinsWashington University School of Medicine6 years of reported clinical research
Expert in Squamous Cell Carcinoma
Expert in Head and Neck Squamous Cell Carcinoma
38 reported clinical trials
64 drugs studied
Saiama N. WaqarWashington University School of Medicine4 years of reported clinical research
Expert in Lung Cancer
Expert in Non-Small Cell Lung Cancer
24 reported clinical trials
48 drugs studied
Kian-Huat Lim, M.D., Ph.D.Washington University School of Medicine7 years of reported clinical research
Expert in Pancreatic Cancer
Studies Rectal Cancer
24 reported clinical trials
54 drugs studied
Tanner M Johanns, M.D., Ph.D.Washington University School of Medicine3 years of reported clinical research
Studies Glioblastoma
Studies Brain Tumor
24 reported clinical trials
40 drugs studied
Clinical Trials running at Memorial Hospital East
Lung Cancer
Skin Cancer
Breast Cancer
Breast cancer
Cancer
Prostate Cancer
Colorectal Cancer
Bladder Cancer
Kidney Cancer
Pancreatic Cancer
Immunotherapy + Chemotherapy
for Non-Small Cell Lung Cancer
This phase III ALCHEMIST treatment trial tests the addition of pembrolizumab to usual chemotherapy for the treatment of stage IIA, IIB, IIIA or IIIB non-small cell lung cancer that has been removed by surgery. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs, such as cisplatin, pemetrexed, carboplatin, gemcitabine hydrochloride, and paclitaxel, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving pembrolizumab with usual chemotherapy may help increase survival times in patients with stage IIA, IIB, IIIA or IIIB non-small cell lung cancer.
Recruiting2 awards Phase 327 criteria
High-Dose Radiation + Chemotherapy and Immunotherapy
for Non-Small Cell Lung Cancer
This trial tests whether adding a precise form of radiation therapy to the usual treatment improves outcomes for patients with advanced lung cancer that can't be operated on. The goal is to see if this combination helps patients live longer and prevents cancer from worsening. This form of radiation therapy has shown promise in improving survival rates in patients with various stages of lung cancer.
Recruiting2 awards Phase 314 criteria
Proton Craniospinal Radiation
for Cancer in the Brain and Spinal Cord
This phase III trial compares proton craniospinal irradiation (pCSI) to involved-field radiation therapy (IFRT) for the treatment of breast or non-small cell lung cancer that has spread from where it first started to the cerebrospinal fluid filled space that surrounds the brain and spinal cord (leptomeningeal metastasis). Patients with leptomeningeal metastasis (LM) may develop multiple areas of nervous system (neurologic) impairment that can be life-threatening. Radiation therapy (RT) effectively relieves local symptoms due to LM. RT uses high energy radiography (x-rays), particles, or radioactive seeds to kill cancer cells and shrink tumors. IFRT is commonly used to treat symptoms of LM. IFRT is radiation treatment that uses x-rays to treat specific areas of LM and to relieve and/or prevent symptoms. pCSI uses protons that can be directed with more accuracy than x-rays which allows treatment of the entire central nervous system space containing the cerebrospinal fluid (CSF), brain, and spinal cord. The pCSI treatment could delay the worsening of LM. Giving pCSI may be better than IFRT in treating LM in patients with breast or non-small cell lung cancer.
Recruiting2 awards Phase 33 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Memorial Hospital East?
Memorial Hospital East is a medical facility located in O'Fallon, Illinois. This center is recognized for care of Breast Cancer, Lung Cancer, Breast cancer, Cancer, Pancreatic Cancer and other specialties. Memorial Hospital East is involved with conducting 35 clinical trials across 116 conditions. There are 27 research doctors associated with this hospital, such as Douglas R. Adkins, Saiama N. Waqar, Kian-Huat Lim, M.D., Ph.D., and Tanner M Johanns, M.D., Ph.D..
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.